Skip to main content
. 2020 Aug 31;6(1):33–38. doi: 10.17996/anc.20-00128

Table 1. Clinical characteristics of the study population.

Characteristic Total (N=234) TGCV (n=104) non-TGCV (n=130) p-value/FDR adjusted p-value

Age (years)
63.3 ± 13.7
64.6 ± 12.9
62.3 ± 14.3
0.21/0.62

Sex (male)
173 (74%)
77 (74%)
96 (74%)
0.97/0.97

Height (cm)
163 ± 9.3
163 ± 9.8
163 ± 9.0
0.95/0.97

Body weight (kg)
62.0 ± 14.5
61.7 ± 14.8
62.3 ± 14.3
0.79/0.95

Body mass index (kg/m2)
23.1 ± 4.3
23.0 ± 4.2
23.2 ± 4.4
0.74/0.95
Coronary artery disease Total  146 (62%) Total  78 (75%) Total  68 (52%) 0.0004/0.004

Heart Coronary artery disease (details) 1-vessel   28 (12%) 1-vessel   14 (13%) 1-vessel   14 (11%)
2-vessel   37 (16%) 2-vessel   20 (19%) 2-vessel   17 (13%)
3-vessel   54 (23%) 3-vessel   31 (30%) 3-vessel   23 (18%)
LMT       15 (6%) LMT         8 (8%) LMT         7 (5%)
CSA        18 (8%) CSA        10 (10%) CSA          8 (6%)

Heart failure or cardiac dysfunction of unknown etiology
47 (20%)
22 (21%)
25(20%)
0.72/0.95
Post-resuscitation
14 (6%)
8 (8%)
6 (5%)
0.32/0.78
LVEF (%) 41.1 ± 18.7 38.1 ± 18.0 43.6 ± 18.9 0.026/0.15

Hypertension
97 (41%)
45 (43%)
52 (40%)
0.61/0.95
Comorbidity Diabetes mellitus
113 (48%)
58 (56%)
55 (42%)
0.041/0.16
Dyslipidemia
101 (43%)
43 (41%)
58 (45%)
0.62/0.95

Continuous values were reported as mean ± standard deviation. Demographic and clinical characteristics were compared between TGCV and non-TGCV using Welch's t tests for continuous variables and chi-square tests for binary variables. Multiple comparison was performed using Benjamini-Hochberg procedure with false discovery rate threshold of 0.05.

CSA: Coronary spastic angina, FDR: False discovery rate, LMT: Left main trunk, LVEF: Left ventricular ejection fraction